# The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

> **NCT06111508** · NA · COMPLETED · sponsor: **University of Virginia** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs

## Key facts

- **NCT ID:** NCT06111508
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-29
- **Primary completion:** 2024-09-13
- **Final completion:** 2024-09-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111508, "The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06111508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
